Invitations to Investors Conferences and Annual Report Filings - Research Report on Haemonetics, Insulet, DexCom, HeartWare, and Mindray Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, June 11, 2013 NEW YORK, June 11, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Haemonetics Corp. (NYSE: HAE), Insulet Corporation (NASDAQ: PODD), DexCom, Inc. (NASDAQ: DXCM), Heartware International Inc. (NASDAQ: HTWR), and Mindray Medical International Limited (NYSE: MR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Haemonetics Corp. Research Report On June 5, 2013, Haemonetics Corp. (Haemonetics) announced that Brian Concannon, President and Chief Executive Officer of the Company, will present at The William Blair 33rd Annual Growth Stock Conference in Chicago on June 13, 2013 at 11:00 a.m. ET. The Full Research Report on Haemonetics Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.WSReports.com/r/full_research_report/7366_HAE] -- Insulet Corporation Research Report On May 5, 2013, Insulet Corporation (Insulet), the leader in tubeless insulin pump technology with its OmniPod Insulin Management System, announced that the Company will participate at The William Blair Growth Stock Conference to be held from June 11 to June 13, 2013 at the Four Seasons Chicago. Management is scheduled to present an overview of the Company on Wednesday, June 12, 2013 at 2:40 p.m. CT (3:40 p.m. ET). During the presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. The live audio webcast of the presentation can be accessed at the Investors Relations section of the Company website. A replay of the webcast will be available for 10 days from the day of the initial presentation. The Full Research Report on Insulet Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/7fe0_PODD] -- DexCom, Inc. Research Report On June 4, 2013, DexCom, Inc. (DexCom) announced that Terry Gregg, Chief Executive Officer, will present an update on the Company at the William Blair Growth Stock Conference in Chicago on Tuesday, June 11, 2013 at 8:50 a.m. (CDT). The Company stated that the presentation, which will occur live at the Four Seasons Hotel, will be concurrently webcast. Further, the Company informed that a link to the webcast will be available on the DexCom website by navigating to "About," then "Investor Relations," and then "Events and Webcasts," and will be archived there for future reference. The Full Research Report on DexCom, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/d67a_DXCM] -- HeartWare International Inc. Research Report On June 4, 2013, HeartWare International Inc. (HeartWare) announced that its Chief Executive Officer, Doug Godshall, is scheduled to present at the Goldman Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 a.m. EDT) on Wednesday, June 12, 2013. The conference will be held from June 11 to June 13, 2013 at the Terranea Resort in Rancho Palos Verdes, CA. A live webcast of the Company's presentation will be accessible via a link provided at the Company website. A replay of the webcast will also be available for 90 days at the site after the presentation. HeartWare is a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure. The Full Research Report on HeartWare International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/086c_HTWR] -- Mindray Medical International Limited Research Report On May 21, 2013, Mindray Medical International Limited (Mindray) announced that it had filed an Annual Report on Form 20-F with the Securities and Exchange Commission in early April 2013, that included audited financial statements for the year ended December 31, 2012. An electronic version of Mindray's Annual Report on Form 20-F is available on Mindray's Investor Relations website. Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. The Full Research Report on Mindray Medical International Limited - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.wsreports.com/r/full_research_report/8545_MR] ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquires, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. SOURCE Wall Street Reports Contact: WSReports.com Phone #: +1-310-496-8071
Invitations to Investors Conferences and Annual Report Filings - Research Report on Haemonetics, Insulet, DexCom, HeartWare, and
Press spacebar to pause and continue. Press esc to stop.